---
figid: PMC6586801__12276_2019_235_Fig2_HTML
figlink: /pmc/articles/PMC6586801/figure/Fig2/
number: F2
caption: During the hypoxic insult, cells release adenosine triphosphate/adenosine
  diphosphate (ATP/ADP) that accumulate in the extracellular space. Hypoxia triggers
  the SP1-dependent induction of CD39 and HIF-dependent induction of CD73, which converts
  ATP to ADP, AMP, and eventually adenosine. HIF also upregulates adenosine receptor
  levels and together with the increased extracellular adenosine, the downstream purinergic
  signaling pathway is activated. Extracellular adenosine could re-enter into the
  cell by equilibrative nucleoside transporters (ENTs) or could be deaminated by CD26-conjugated
  adenosine deaminases (ADAs), all of which function to terminate adenosine signaling.
  Stimulation of adenosine receptors either result in the inhibition of adenylyl cyclase
  (AC) by ADORA1/3 or activation by ADORA2A/2B
pmcid: PMC6586801
papertitle: Hypoxia signaling in human diseases and therapeutic targets.
reftext: Jae W. Lee, et al. Exp Mol Med. 2019 Jun;51(6):68.
pmc_ranked_result_index: '32036'
pathway_score: 0.9685029
filename: 12276_2019_235_Fig2_HTML.jpg
figtitle: Hypoxia signaling in human diseases and therapeutic targets
year: '2019'
organisms:
- Mus musculus
- Rattus norvegicus
- Mirabilis mosaic virus
- Escherichia coli
- Homo sapiens
- Oryctolagus cuniculus
ndex: 97226581-deb2-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6586801__12276_2019_235_Fig2_HTML.html
  '@type': Dataset
  description: During the hypoxic insult, cells release adenosine triphosphate/adenosine
    diphosphate (ATP/ADP) that accumulate in the extracellular space. Hypoxia triggers
    the SP1-dependent induction of CD39 and HIF-dependent induction of CD73, which
    converts ATP to ADP, AMP, and eventually adenosine. HIF also upregulates adenosine
    receptor levels and together with the increased extracellular adenosine, the downstream
    purinergic signaling pathway is activated. Extracellular adenosine could re-enter
    into the cell by equilibrative nucleoside transporters (ENTs) or could be deaminated
    by CD26-conjugated adenosine deaminases (ADAs), all of which function to terminate
    adenosine signaling. Stimulation of adenosine receptors either result in the inhibition
    of adenylyl cyclase (AC) by ADORA1/3 or activation by ADORA2A/2B
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ADCY6
  - ADCY1
  - ADCY5
  - ADCY7
  - ADCY8
  - ADCY4
  - ADCY10
  - ADA
  - ADCY9
  - ADORA1
  - ADORA2A
  - ADORA2B
  - ADORA3
  - ADCY2
  - ADCY3
  - DPP4
  - ENTPD1
  - NT5E
  - ARNT2
  - EPAS1
  - HIF1A
  - ARNT
  - ARNTL
  - HIF3A
  - WDTC1
  - MFAP1
  - Adenosine
  - ADP
  - AMP
  - Inosine
genes:
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY6
  entrez: '112'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY1
  entrez: '107'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY5
  entrez: '111'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY7
  entrez: '113'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY8
  entrez: '114'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY4
  entrez: '196883'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY10
  entrez: '55811'
- word: ADA
  symbol: ADA
  source: hgnc_symbol
  hgnc_symbol: ADA
  entrez: '100'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY9
  entrez: '115'
- word: ADORA1/3ADORA2A/2B
  symbol: ADORA1
  source: hgnc_symbol
  hgnc_symbol: ADORA1
  entrez: '134'
- word: ADORA2A/2B
  symbol: ADORA2A
  source: hgnc_symbol
  hgnc_symbol: ADORA2A
  entrez: '135'
- word: ADORA2A/2B
  symbol: ADORA2B
  source: hgnc_symbol
  hgnc_symbol: ADORA2B
  entrez: '136'
- word: ADORA1/3
  symbol: ADORA3
  source: hgnc_symbol
  hgnc_symbol: ADORA3
  entrez: '140'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY2
  entrez: '108'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY3
  entrez: '109'
- word: CD26
  symbol: CD26
  source: hgnc_prev_symbol
  hgnc_symbol: DPP4
  entrez: '1803'
- word: CD39
  symbol: CD39
  source: hgnc_prev_symbol
  hgnc_symbol: ENTPD1
  entrez: '953'
- word: CD73
  symbol: CD73
  source: hgnc_alias_symbol
  hgnc_symbol: NT5E
  entrez: '4907'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNT2
  entrez: '9915'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: EPAS1
  entrez: '2034'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNT
  entrez: '405'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNTL
  entrez: '406'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: HIF3A
  entrez: '64344'
- word: ADP
  symbol: ADP
  source: hgnc_alias_symbol
  hgnc_symbol: WDTC1
  entrez: '23038'
- word: AMP
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: ENT
  symbol: eNT
  source: hgnc_alias_symbol
  hgnc_symbol: NT5E
  entrez: '4907'
chemicals:
- word: Adenosine
  source: MESH
  identifier: D000241
- word: ADP
  source: MESH
  identifier: D000244
- word: AMP
  source: MESH
  identifier: D000249
- word: Inosine
  source: MESH
  identifier: D007288
diseases: []
figid_alias: PMC6586801__F2
redirect_from: /figures/PMC6586801__F2
figtype: Figure
---
